Mathias Busch

Mathias Busch

Auto-generated profile, based on publicly available information

Mathias Busch

Division of Toxicology, Wageningen University & Research, Wageningen, the Netherlands

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Environmental Research
Verified
Journal Article
Closed access
MBMathias Busch
Mathias Busch
GBGerrit Bredeck
Gerrit Bredeck
AKAngela A.M. Kämpfer
Angela A.M. Kämpfer
RSRoel Schins
Roel Schins

1 December 2021 in Chemosphere
Verified
Journal Article
Open access
MBMathias Busch
Mathias Busch
AKAngela A.M. Kämpfer
Angela A.M. Kämpfer
RSRoel Schins
Roel Schins
As environmental pollution with plastic waste is increasing, numerous reports show the contamination of natural habitats, food and drinking water with plastic particles in the micro- and nanometer range. Since oral exposure to these particles is virtually unavoidable, health concerns towards the general population have been expressed and risk assessment regarding ingested plastic particles is of great interest. To study the intestinal effects of polymeric particles with a density of <1 g/cm³ in vitro, we spatially inverted a triple culture transwell model of the healthy and inflamed intestine (Caco-2/HT29-MTX-E12/THP-1), which allows contact between buoyant particles and cells. We validated the inverted model against the original model using the enterotoxic, non-steroidal anti-inflammatory drug diclofenac and subsequently assessed the cytotoxic and pro-inflammatory effects of polyethylene (PE) microparticles. The results show that the inverted model exhibits the same distinct features as the original model in terms of barrier development and inflammatory parameters. Treatment with 2 mM diclofenac causes severe cytotoxicity, DNA damage and complete barrier disruption in both models. PE particles induced cytotoxicity and pro-inflammatory effects in the inverted model, which would have remained undetected in conventional in vitro approaches, as no effect was observed in non-inverted control cultures.

17 June 2025 in Journal of Hazardous Materials
Verified
Journal Article
Open access
HBHugo Brouwer
Hugo Brouwer
MBMathias Busch
Mathias Busch
SYShuo Yang
Shuo Yang
TVTom Venus
Tom Venus
Germaine AalderinkGermaine Aalderink
Germaine Aalderink
HBHans Bouwmeester
Hans Bouwmeester
Humans are continually exposed to microplastics, now pervasive in the environment. The intestinal epithelium, as a primary barrier tissue, frequently faces high microplastic exposure, yet health implications remain elusive. Using an intestinal epithelial cell model derived from human induced pluripotent stem cells, we show intestinal toxicity upon exposure to true-to-life polyethylene terephthalate-TiO2, polypropylene-Talc, polyvinyl chloride and polyamide microplastics. These materials compromised barrier integrity, elevated intracellular reactive oxygen species and stimulated intestinal cytokine secretion. Epithelial perturbations were not observed upon exposure to polystyrene microplastics, which frequently serve as a proxy for product-derived microplastic exposure. Proteomics analysis identified unique protein corona compositions for each microplastic, which correlated with in vitro effects. For example, the abundance of biocorona proteins involved in inflammation strongly correlated to the degree of cytokine secretion. These findings underscore the need for routine availability of true-to-life microplastics and protein corona analysis in hazard assessment to enable safe-by-design plastic development.

9 September 2024 in Archives of Toxicology
Verified
Journal Article
Open access
PDF file
TWTom Johannes Gerardus Walraven
Tom Johannes Gerardus Walraven
MBMathias Busch
Mathias Busch
JWJingxuan Wang
Jingxuan Wang
JDJoanne Donkers
Joanne Donkers
MDMarjolijn Duijvestein
Marjolijn Duijvestein
HBHans Bouwmeester
Hans Bouwmeester
The global burden of Inflammatory bowel disease (IBD) has been rising over the last decades. IBD is an intestinal disorder with a complex and largely unknown etiology. The disease is characterized by a chronically inflamed gastrointestinal tract, with intermittent phases of exacerbation and remission. This compromised intestinal barrier can contribute to, enhance, or even enable the toxicity of drugs, food-borne chemicals and particulate matter. This review discusses whether the rising prevalence of IBD in our society warrants the consideration of IBD patients as a specific population group in toxicological safety assessment. Various in vivo, ex vivo and in vitro models are discussed that can simulate hallmarks of IBD and may be used to study the effects of prevalent intestinal inflammation on the hazards of these various toxicants. In conclusion, risk assessments based on healthy individuals may not sufficiently cover IBD patient safety and it is suggested to consider this susceptible subgroup of the population in future toxicological assessments.

30 March 2026 in Toxicology
Verified
Journal Article
Open access
GSGijs J.J. van Slobbe
Gijs J.J. van Slobbe
MBMathias Busch
Mathias Busch
WBWouter Bakker
Wouter Bakker
CGCoen Govers
Coen Govers
HBHans Bouwmeester
Hans Bouwmeester
Embedding immune responsiveness is relevant for hepatotoxic testing strategies, as inflammation can affect the kinetics of compounds by modulation of drug-metabolizing enzymes and transporters (DMETs), and because inflammation is thought to explain some cases of idiosyncratic drug-induced liver injury (iDILI). Therefore, this study applied HepaRG monocultures and HepaRG:THP-1 macrophage cocultures as immune responsive hepatotoxicity models. To induce inflammation, HepaRG and THP-1 macrophages in mono- and coculture were stimulated with lipopolysaccharide (LPS) combined with interferon gamma (IFNγ). Proinflammatory cytokines interleukin (IL)6, IL8, IL1β and tumor necrosis factor alpha (TNFα) were quantified to verify an inflamed-like state. Our results showed that LPS and IFNγ elicited an inflamed-like state in both culture models, characterized by an increase in cytokine secretion. Next, mRNA expression and activity of DMETs was assessed in the stable and inflamed mono- and coculture model. Inflammation reduced the mRNA expression and activity of cytochrome P450 (CYP) enzymes, but did not reduce the mRNA expression and activity of efflux transporters in HepaRG mono- and cocultures. Finally, models were exposed to iDILI drugs diclofenac (200µM), trovafloxacin (100µM) and clozapine (75µM), whereafter cell viability and cytotoxicity was measured. The iDILI drugs induced a synergistic decrease in viability in inflamed HepaRG mono- and cocultures, which showcases predictivity of the model for iDILI hepatotoxic reactions. In conclusion, HepaRG cells in monoculture and in coculture with THP-1 macrophages showed similar inflammation-driven effects on the selected endpoints, which shows that both models are promising tools to evaluate inflammation-driven effects on toxicokinetic and toxicodynamic endpoints.